CalciMedica, Inc. (CALC)
CALC moved a median of -0.09% 30 minutes after news, and 0.00% by the close. How CALC actually reacts to news — the realized, point-in-time move the market made, measured across 280 labeled events over the last three years with zero look-ahead.
CALC’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 33% | 213 |
| 30-min | -0.09% | 45% | 256 |
| 60-min | -0.02% | 47% | 270 |
| to close | 0.00% | 45% | 276 |
| Middle 50% of CALC reactions | -2.54% to +2.19% |
|---|---|
| Median reaction (30-min) | -0.09% |
| Measured reactions | 280 |
Half of all CalciMedica, Inc. news events land between -2.54% and +2.19% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How CALC reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Coverage initiations | 11 | +4.53% | 64% | -4.47% |
| Rating reiterations | 25 | -0.68% | 40% | -0.93% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 4 further classes were observed with fewer than 10 measured events and are not published. See how CALC ranks against every other measured name →
That’s how CALC usually reacts — get an email when it moves on news →Email me when CALC moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to CALC's baseline. Nothing else.
Recent CALC events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 8-K CalciMedica, Inc. For: Oct 15 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -0.97% | |
| Form 8-K CalciMedica, Inc. For: Sep 30 | SEC filing · Form 8-K | SEC EDGAR | +1.85% | +1.85% | |
| Form S-8 CalciMedica, Inc. | SEC filing · Form S-8 | SEC EDGAR | -0.55% | -3.87% | |
| Form 8-K CalciMedica, Inc. For: Sep 15 | SEC filing · Form 8-K | SEC EDGAR | — | -1.99% | |
| Form 8-K CalciMedica, Inc. For: Aug 31 | SEC filing · Form 8-K | SEC EDGAR | — | -5.55% | |
| CalciMedica to Participate in the H.C. Wainwright 28th Annual Global Investment Conference | Press release | GlobeNewswire | +1.90% | -4.26% | |
| Form 8-K CalciMedica, Inc. For: Aug 31 | SEC filing · Form 8-K | SEC EDGAR | +3.96% | +3.96% | |
| CalciMedica Announces One-for-Five Reverse Stock Split | Press release | GlobeNewswire | +1.89% | -11.35% | |
| Form 8-K CalciMedica, Inc. For: Aug 27 | SEC filing · Form 8-K | SEC EDGAR | +1.89% | -11.35% | |
| Form 8-K CalciMedica, Inc. For: Aug 19 | SEC filing · Form 8-K | SEC EDGAR | -4.76% | -7.43% | |
| CalciMedica Reports Second Quarter 2026 Financial Results and Provides Clinical & Corporate Updates | Press release | GlobeNewswire | -1.29% | -1.65% | |
| Form 10-Q CalciMedica, Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -0.61% | -6.08% | |
| Form 8-K CalciMedica, Inc. For: Aug 11 | SEC filing · Form 8-K | SEC EDGAR | -1.29% | -1.65% | |
| Form EFFECT CalciMedica, Inc. | SEC filing · Form EFFECT | SEC EDGAR | +0.93% | -20.87% | |
| CalciMedica Announces FDA Alignment on Phase 2b Trial Design for Auxora in Acute Pancreatitis and Identifies Disease's First Potential Registrational Endpoints | Press release | PR Newswire | +7.23% | +5.48% | |
| Form S-3 CalciMedica, Inc. | SEC filing · Form S-3 | SEC EDGAR | -5.25% | -4.44% | |
| Form ARS CalciMedica, Inc. For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | — | +5.92% | |
| Form DEF 14A CalciMedica, Inc. For: Aug 19 | SEC filing · Form DEF | SEC EDGAR | — | +5.92% | |
| Form PRE 14A CalciMedica, Inc. For: Aug 19 | SEC filing · Form PRE | SEC EDGAR | +0.54% | -8.48% | |
| Form 8-K CalciMedica, Inc. For: Jul 02 | SEC filing · Form 8-K | SEC EDGAR | -3.87% | -3.98% | |
| CalciMedica Announces Clinical Development of Auxora May Proceed Following FDA Review of KOURAGE Trial Interim Safety Data | Press release | PR Newswire | -1.09% | -25.34% | |
| CalciMedica Announces Private Placement Financing for Up to Approximately $49 Million to Advance Pulmonary Hypertension Program | Press release | PR Newswire | -1.09% | -25.34% | |
| Form 8-K CalciMedica, Inc. For: Jun 23 | SEC filing · Form 8-K | SEC EDGAR | -1.09% | -25.34% | |
| CalciMedica Reports First Quarter 2026 Financial Results and Provides Clinical & Corporate Updates | Press release | PR Newswire | +0.00% | +2.32% | |
| Form 10-Q CalciMedica, Inc. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +1.45% | +12.56% | |
| Form 8-K CalciMedica, Inc. For: May 12 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +2.32% | |
| Form 10-K/A CalciMedica, Inc. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +0.00% | -1.90% | |
| Form 8-K CalciMedica, Inc. For: Mar 13 | SEC filing · Form 8-K | SEC EDGAR | -0.79% | -5.10% | |
| Form EFFECT CalciMedica, Inc. | SEC filing · Form EFFECT | SEC EDGAR | -0.58% | +2.37% | |
| CalciMedica Reports 2025 Financial Results and Provides Clinical Updates | Press release | PR Newswire | +0.00% | +3.61% | |
| Form 10-K CalciMedica, Inc. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | -2.90% | +5.73% | |
| Form 8-K CalciMedica, Inc. For: Mar 02 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +3.61% | |
| Form S-3 CalciMedica, Inc. | SEC filing · Form S-3 | SEC EDGAR | -2.90% | +5.73% | |
| CalciMedica Announces Discontinuation of Phase 2 KOURAGE Trial in AKI Following Independent Data Monitoring Committee Recommendation | Press release | PR Newswire | +2.83% | +47.06% | |
| Form 8-K CalciMedica, Inc. For: Jan 28 | SEC filing · Form 8-K | SEC EDGAR | +2.83% | +47.06% | |
| CalciMedica Announces Publication in JCI Insight of Preclinical Data Supporting CRAC Channel Inhibitor as a Potential Therapy for Pulmonary Arterial Hypertension | Press release | PR Newswire | +0.62% | +4.05% | |
| CalciMedica Reports Third Quarter 2025 Financial Results and Provides Clinical & Corporate Updates | Press release | PR Newswire | +0.62% | +4.05% | |
| Form 10-Q CalciMedica, Inc. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.92% | — | |
| Form 8-K CalciMedica, Inc. For: Nov 12 | SEC filing · Form 8-K | SEC EDGAR | +0.62% | +4.05% | |
| CalciMedica Presents Data from Preclinical Study of Auxora™ in an Animal Model of AKI at ASN Kidney Week 2025 | Press release | PR Newswire | +0.00% | -2.24% | |
| Form 8-K CalciMedica, Inc. For: Nov 06 | SEC filing · Form 8-K | SEC EDGAR | — | +2.01% | |
| CalciMedica and Telperian Announce Collaboration to Integrate Innovative Artificial Intelligence Engine to Analysis of Clinical Trials of Auxora™ | Press release | PR Newswire | -0.61% | -1.51% | |
| CalciMedica to Participate in the H.C. Wainwright 27th Annual Global Investment Conference | Press release | PR Newswire | -0.36% | +12.73% | |
| CalciMedica Reports Second Quarter 2025 Financial Results and Provides Clinical & Corporate Updates | Press release | PR Newswire | -0.12% | — | |
| Form 10-Q CalciMedica, Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | -3.07% | |
| Form 8-K CalciMedica, Inc. For: Aug 12 | SEC filing · Form 8-K | SEC EDGAR | -0.99% | — | |
| CalciMedica to Participate in the H.C. Wainwright 4th Annual Kidney Virtual Conference | Press release | PR Newswire | — | -1.85% | |
| Form 8-K CalciMedica, Inc. For: Jun 24 | SEC filing · Form 8-K | SEC EDGAR | +1.41% | +12.68% | |
| Form S-8 POS CalciMedica, Inc. | SEC filing · Form S-8 | SEC EDGAR | +1.41% | +12.68% | |
| CalciMedica Announces Publication in the American Journal of Nephrology Discussing Design and Rationale of Phase 2 KOURAGE Trial of Auxora™ in AKI with Respiratory Failure | Press release | PR Newswire | -0.59% | -7.10% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the CALC section they belong to.
Where else CALC is measured.
CALC earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is CalciMedica, Inc.'s median reaction calculated?
Every labeled CALC news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 280 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 45% of CALC's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does CALC's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.